Seppo W. Langer

Seppo W. Langer

Clinical Associate Professor

Member of:

  • Clinical Oncology

ORCID: 0000-0001-9732-9192

Publication year:
All
11 - 20 out of 174Page size: 10
  1. 1996
  2. Published

    Untersuchung der Wirksamkeit eines Materials zur Druck-entlastung bei der Prophylaxe und Behandlung von Druckulzera

    Langer, Seppo W., Jun 1996, In: Krankenpflege Journal. 34, 6, p. 263-5 3 p.

    Research output: Contribution to journal › Journal article › Research › peer-review

  3. Published

    Brain relapses in chemotherapy-treated small cell lung cancer: A retrospective review of two time-dose regimens of therapeutic brain irradiation

    Bach, F., Sørensen, Jens Benn, Adrian, L., Larsen, H., Langer, Seppo W., Nelausen, K. M. & Engelholm, S. A., Sep 1996, In: Lung Cancer. 15, 2, p. 171-181 11 p.

    Research output: Contribution to journal › Review › Research › peer-review

  4. 1999
  5. Published

    Granisetron compared with prednisolone plus metopimazine as anti-emetic prophylaxis during multiple cycles of moderately emetogenic chemotherapy

    Sigsgaard, T., Herrstedt, Jørn, Andersen, L. J., Havsteen, H., Langer, Seppo W., Kjærbøl, A. G., Lund, H., Kjær, Michael & Dombernowsky, P., 1999, In: British Journal of Cancer. 80, 3-4, p. 412-418 7 p.

    Research output: Contribution to journal › Journal article › Research › peer-review

  6. Published

    Inhibitors of topoisomerase II as pH-dependent modulators of etoposide- mediated cytotoxicity

    Langer, Seppo W., Schmidt, G., Sørensen, M., Sehested, M. & Jensen, P. B., Oct 1999, In: Clinical Cancer Research. 5, 10, p. 2899-2907 9 p.

    Research output: Contribution to journal › Journal article › Research › peer-review

  7. Published

    Twenty-five years of chemotherapy in small cell lung cancer sends us back to the laboratory

    Jensen, P. B., Sehested, M., Langer, Seppo W. & Hansen, H. H., Dec 1999, In: Cancer Treatment Reviews. 25, 6, p. 377-386 10 p.

    Research output: Contribution to journal › Journal article › Research › peer-review

  8. 2000
  9. Published

    Dexrazoxane in anthracycline extravasation [4]

    Langer, Seppo W., Sehested, M., Jensen, P. B., Buter, J. & Giaconne, G., 2000, In: Journal of Clinical Oncology. 18, 16, p. 3064 1 p.

    Research output: Contribution to journal › Letter › Research › peer-review

  10. Published

    Treatment of anthracycline extravasation with dexrazoxane

    Langer, Seppo W., Sehested, M. & Jensen, P. B., 2000, In: Clinical Cancer Research. 6, 9, p. 3680-3686 7 p.

    Research output: Contribution to journal › Journal article › Research › peer-review

  11. Published

    Dexrazoxane in anthracycline extravasation

    Langer, Seppo W., Sehested, M., Jensen, P. B., Buter, J. & Giaccone, G., Aug 2000, In: Journal of Clinical Oncology. 18, 16, p. 3064

    Research output: Contribution to journal › Journal article › Research › peer-review

  12. 2001
  13. Published

    Dexrazoxane is a potent and specific inhibitor of anthracycline induced subcutaneous lesions in mice

    Langer, Seppo W., Sehested, M. & Jensen, P. B., Mar 2001, In: Annals of oncology : official journal of the European Society for Medical Oncology. 12, 3, p. 405-10 6 p.

    Research output: Contribution to journal › Journal article › Research › peer-review

  14. 2002
  15. Published

    Maleimide is a potent inhibitor of topoisomerase II in vitro and in vivo: a new mode of catalytic inhibition

    Jensen, L. H., Renodon-Corniere, A., Wessel, I., Langer, Seppo W., Søkilde, B., Carstensen, E. V., Sehested, M. & Jensen, P. B., May 2002, In: Molecular Pharmacology. 61, 5, p. 1235-43 9 p.

    Research output: Contribution to journal › Journal article › Research › peer-review

Previous 1 2 3 4 5 6 7 8 ...18 Next

ID: 33841728